FIELD: biotechnology.
SUBSTANCE: disclosed is a synthetic analogue of natural nucleic bases.
EFFECT: invention can be used to expand the genetic code, in particular when producing new codons having no natural function and difficulties, but recognition of which in ribosomes is, in fact, more orthogonal.
22 cl, 8 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS BASED ON NON-NATURAL BASE PAIRS AND METHODS OF THEIR USE | 2018 |
|
RU2799441C2 |
| CYTOKINE CONJUGATES FOR TREATMENT OF AUTOIMMUNE DISEASES | 2018 |
|
RU2787201C2 |
| GENETICALLY PROGRAMMED EXPRESSION OF PROTEINS CONTAINING UNNATURAL AMINO ACID PHENYL-SELENOCYSTEINE | 2007 |
|
RU2464315C2 |
| CYTOKINE CONJUGATES FOR TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES | 2018 |
|
RU2786116C2 |
| IL-15 CONJUGATES AND THEIR USES | 2019 |
|
RU2793754C2 |
| AMINOACIL-tRNA SYNTHASE FOR EFFECTIVE INTRODUCTION OF LYSINE DERIVATIVE INTO PROTEIN | 2020 |
|
RU2799794C2 |
| INTERLEUKIN 10 CONJUGATES AND OPTIONS FOR THEIR USE | 2019 |
|
RU2815891C2 |
| GENETIC CODED FLUORESCENT COUMARINIC AMINO ACIDS | 2007 |
|
RU2473690C2 |
| SELECTIVE POST-TRANSLATIONAL MODIFICATION OF PHAGE-DISPLAYED POLYPEPTIDES | 2006 |
|
RU2459866C2 |
| HYSTIDIL-TRNA-SYNTHETASE FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES | 2013 |
|
RU2659423C2 |
